KRM AYURVEDA LIMITED vs TORRENT PHARMACEUTICALS L
A side-by-side comparison of KRM AYURVEDA LIMITED (KRMAYURVED) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, KRM AYURVEDA LIMITED leads KRMAYURVED vs TORNTPHARM on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability31
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
KRMAYURVED takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
KRMAYURVED takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
KRMAYURVED takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
TORNTPHARM takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 36.7%"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Debtor days have increased from 56.5 to 81.6 days.", "Working capital days have increased from 131 days to 280 days"]
- + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
- − ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.